Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Erlotinib | 0.1 | uM | 9 | 156.25 | 71.09 | 138.00 | 119.50 | 1.1548 | 1.4236 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 156.25 | 71.09 | 301.00 | 119.50 | 2.5188 | 5.8625 |
| BT-20 | Erlotinib | 1 | uM | 9 | 156.25 | 71.09 | 112.00 | 119.50 | 0.9372 | 0.8343 |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 156.25 | 71.09 | 94.00 | 119.50 | 0.7866 | 0.4518 |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 138.00 | 119.50 | 1.1548 | 1.4236 | |
| BT-20 | Linsitinib | 1 | uM | 9 | 156.25 | 71.09 | 162.00 | 119.50 | 1.3556 | 2.0019 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 156.25 | 71.09 | 147.00 | 119.50 | 1.2301 | 1.6368 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 156.25 | 71.09 | 128.00 | 119.50 | 1.0711 | 1.1921 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 156.25 | 71.09 | 196.00 | 119.50 | 1.6402 | 2.8710 |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 132.00 | 119.50 | 1.1046 | 1.2840 | |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 156.25 | 71.09 | 103.00 | 119.50 | 0.8619 | 0.6402 |
| BT-20 | Erlotinib | 10 | uM | 9 | 156.25 | 71.09 | 128.00 | 119.50 | 1.0711 | 1.1921 |
| BT-20 | 17-AAG | 0.001 | uM | 9 | 156.25 | 71.09 | 124.00 | 119.50 | 1.0377 | 1.1011 |
| BT-20 | Lapatinib | 10 | uM | 9 | 156.25 | 71.09 | 47.00 | 119.50 | 0.3933 | -0.4244 |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 143.00 | 119.50 | 1.1967 | 1.5415 | |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 127.00 | 119.50 | 1.0628 | 1.1693 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 156.25 | 71.09 | 116.00 | 119.50 | 0.9707 | 0.9222 |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 53.00 | 119.50 | 0.4435 | -0.3243 | |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 111.00 | 119.50 | 0.9289 | 0.8124 | |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 156.25 | 71.09 | 96.00 | 119.50 | 0.8034 | 0.4932 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 156.25 | 71.09 | 181.00 | 119.50 | 1.5146 | 2.4808 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 156.25 | 71.09 | 51.00 | 119.50 | 0.4268 | -0.3581 |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 156.25 | 71.09 | 74.00 | 119.50 | 0.6193 | 0.0550 |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 156.25 | 71.09 | 123.00 | 119.50 | 1.0293 | 1.0786 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 156.25 | 71.09 | 114.00 | 119.50 | 0.9540 | 0.8781 |